Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Manage your formulary budget
Find generic entry opportunities
Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Water-soluble, non-ionizing hydroxy-containing amide derivatives of 2,4,6-triiodo-isophthalic acid|
|Abstract:||Compounds of the formula ##STR1## wherein R and R.sub.1 are 1,3-dihydroxyisopropyl or 2,3-dihydroxypropyl, and R.sub.2 is hydrogen or hydroxyl, are readily water-soluble and of sufficiently low toxicity for use as radiopaque materials in the radiography of body cavities as in urography, angiography, ventriculography, and myelography.|
|Inventor(s):||Felder; Ernst (Riva S. Vitale, CH), Pitre; David E. (Milan, IT)|
|Assignee:||Savac AG (Chur, CH)|
Patent Claim Types:|
see list of patent claims
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Switzerland||16588/74||Dec 13, 1974|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.